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INTRODUCTION
THE POOR REGENERATIVE PROPERTIES of articular carti-lage often necessitate surgical intervention after in-
jury or degenerative disease.1–5 However, current thera-
pies such as osteochondral grafting, chondroplasty, and
prosthetic joint replacement have only partial or tempo-
rary success due to inadequate donor tissue availability,
donor site morbidity, the risk of infection, abrasion of the
cartilage surface, loosening of implants, and limited dura-
bility of prosthetics.6–8 Tissue-engineering approaches
have the potential to overcome the lack of donor tissue
and to create a graft that contains biologically and me-
chanically functional tissue. A variety of tissue-engi-
neering techniques have been developed to regenerate
bone and cartilage.9–16 These studies have illustrated that
engineered cartilage must integrate with the host tissue,
provide a smooth and natural articulating surface, and
bear functional mechanical loads. In attempts to satisfy
these requirements, investigators have used a variety of
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ABSTRACT
Tissue engineering has provided an alternative to traditional strategies to repair cartilage damaged
by injury or degenerative disease. A successful strategy to engineer osteochondral tissue will mimic
the natural contour of the articulating surface, achieve native mechanical properties and functional
load-bearing ability, and lead to integration with host cartilage and underlying subchondral bone.
Image-based design (IBD) and solid free-form (SFF) fabrication can be used to generate scaffolds
that are load bearing and match articular geometry. The objective of this study was to utilize ma-
terials and biological factors in an integrated approach to regenerate a multitissue interface. Bipha-
sic composite scaffolds manufactured by IBD and SFF fabrication were used to simultaneously gen-
erate bone and cartilage in discrete regions and provide for the development of a stable interface
between cartilage and subchondral bone. Poly-L-lactic acid/hydroxyapatite composite scaffolds were
differentially seeded with fibroblasts transduced with an adenovirus expressing bone morphogenetic
protein 7 (BMP-7) in the ceramic phase and fully differentiated chondrocytes in the polymeric phase.
After subcutaneous implantation into mice, the biphasic scaffolds promoted the simultaneous growth
of bone, cartilage, and a mineralized interface tissue. Within the ceramic phase, the pockets of tis-
sue generated included blood vessels, marrow stroma, and adipose tissue. This combination of IBD
and SFF-fabricated biphasic scaffolds with gene and cell therapy is a promising approach to re-
generate osteochondral defects.
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techniques, including mechanically preconditioned engi-
neered cartilage in vitro, to improve load-bearing prop-
erties17,18 and contoured scaffolds to mimic articular sur-
faces.19,20 While varying degrees of success have been
achieved by these approaches, no single technique has
been able to satisfy the requirements of integration with
host tissue, maintenance of a natural articulate contour,
and mechanical function. To satisfy these requirements
and also to generate a bone–cartilage interface along the
entire length of a construct, a biphasic scaffold may be
required.
Biphasic scaffolds are designed to guide the growth of
two different tissues and satisfy different mechanical and
biological requirements. Discrete regions of the scaffold
are optimized for selective growth of the desired tissue
by utilizing different material types, material properties,
internal architectures (e.g., porosity, pore interconnectiv-
ity), and cells and biological factors. Such scaffolds have
been investigated for ostochondral regeneration. In vitro
culture of chondrocytes on scaffolds containing poly-
meric and ceramic phases showed maintenance of chon-
drocyte phenotype.21 Similar scaffolds seeded with chon-
drocytes, cultured in vitro, and then implanted in lapine
osteochondral defects, led to the successful generation of
both bone and cartilage and integration of the scaffold
with the subchondral bone.22 Although these studies es-
tablish the potential of biphasic scaffolds for osteochon-
dral regeneration, scaffolds seeded with both osteoprog-
enitor and chondroprogenitor cells may be necessary to
achieve full integration with the host tissue and mechan-
ical function. This may be particularly true in large de-
fects or those deficient in skeletal progenitor cells. To ad-
dress this limitation, investigators have seeded bone
marrow stromal cells (BMSCs) differentiated into chon-
droblasts or osteoblasts onto hyaluron or ceramic struc-
tures, respectively, and cultured these structures in
vitro.23 Assembly of these structures with fibrin glue cre-
ated a biphasic tissue that, when subcutaneously im-
planted in mice, resulted in the formation of fibrocarti-
lage on the hyaluron and bone on the ceramic regions.23
Taken together, these studies demonstrate the ability of
biphasic scaffolds to support cell growth and differenti-
ation into bone and cartilage. Further, these studies indi-
cate that biphasic scaffolds show promise in promoting
integration with host tissue and sustaining biological
function.
Several limitations must be overcome to achieve suc-
cessful treatment of human articular defects. Ideally, si-
multaneous growth will lead to the production of a min-
eralized tissue interface between cartilage and bone that
will serve as a stiffness transition between both tissues
akin to the tidemark in articular cartilage. Maintenance
of a uniform tidemark may protect articular cartilage
from damaged sustained during functional loading. In-
deed, disruption of the subchondral bone architecture
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has been implicated in osteoarthritis.24,25 Rather than
depending on the assembly of separate living structures
that contain cultured cells, we propose to trigger si-
multaneous growth of bone and cartilage on one inte-
grated biphasic scaffold to improve the mechanical
properties of regenerated tissues.
Precise control over scaffold architecture may be used
to enhance osteochondral regeneration. Control over the
biphasic scaffold internal pore architecture may be used
to create scaffolds with mechanical and biological prop-
erties that provide immediate mechanical function while
promoting tissue ingrowth.26,27 Control over the exterior
shape of the scaffold may be used to match the scaffold
geometry with a defect site or the contours of the artic-
ular surface. Control over scaffold shape may be achieved
using image data and micromilling.28 To create a scaf-
fold with complex internal structures while providing for
rapid and flexible manufacturing, computational design
and solid free-form (SFF) fabrication techniques may be
needed. SFF fabrication has previously been used to cre-
ate biphasic scaffolds. Constructs composed of a porous
poly-lactic-glycolic acid/poly-lactic acid (PLGA/PLA)
upper phase and a porous PLGA/tricalcium phosphate
lower phase provided for selective seeding of chondro-
cytes and the growth of cartilage in vitro.29 However, the
efficacy of SFF scaffolds for biphasic tissue engineering
remains unproven. In addition, the generation of a min-
eralized interface between regenerate cartilage and bone
has not been demonstrated.
The objective of this study was to devise a tissue en-
gineering strategy to regenerate osteochondral tissue in
defects of varied size and shape. Image-based design
(IBD) can be used to design scaffolds that match articu-
lating surface geometry and minimize abrasion of regen-
erate cartilage. SFF fabrication can be used to build scaf-
folds that can bear functional loads, avoiding the need
for preconditioning, while promoting regeneration. We
hypothesized that an integrated composite scaffold may
be used to simultaneously allow growth of both bone 
and cartilage progenitors in discrete regions of the scaf-
fold. This would enhance integration of the scaffold in
the implant site and provide for the development of a
bone–cartilage interface that supplies appropriate me-
chanical support for the articular cartilage. Poly-L-lactic
acid/hydroxyapatite (PLA/HA) discrete composite scaf-
folds were manufactured using IBD and SFF. Fibroblasts
transduced with an adenovirus expressing bone morpho-
genetic protein 7 (BMP-7) were seeded in the ceramic
phase and fully differentiated chondrocytes were seeded
in the polymer phase. Composite scaffolds were subcu-
taneously implanted and grown for 4 weeks in a murine
model. Our biphasic SFF scaffolds supported simultane-
ous growth of cartilage in the PLA phase, bone and blood
vessels in the HA phase, and a mineralized cartilage in-
terface tissue between the two phases.
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MATERIALS AND METHODS
Scaffold design and manufacture
The scaffold shape and internal pore architecture were
defined using an image-based design (IBD) method pre-
viously described.30 IBD allows for the design of scaf-
folds with complex internal pore geometry and an ex-
ternal shape that matches patient-specific implant site
requirements. Composite scaffolds were composed of
two bonded cylinders, one hydroxyapatite (HA) and one
poly-L-lactic acid (PLA, MWweightavg  147,000; Birm-
ingham Polymers, Birmingham, AL), each 5 mm in di-
ameter and 3 mm in height. The HA phase contained 800-
or 300-m-diameter orthogonal pores with a porosity of
50%. These were manufactured by indirect solid free-
form fabrication as previously described.31 Briefly, IBD
data were converted to surface facet representation in
*.STL format, using Imagedes (Voxelcon Computing,
Ann Arbor, MI). The *.STL files were sliced with Mod-
elworks software to create input files for three-dimen-
sional ink jet wax printing on a Model Maker II (Solid-
Scape, Merrimack, NH). An HA and acrylic slurry was
cast into wax molds obtained from the three-dimensional
printer and sintered.32 The polymer sponges were created
by a salt-leaching technique as described previously.31
Sieved NaCl (Sigma, St. Louis, MO) particles 100–120
m in size were packed into custom-made, 5-mm-diam-
eter by 3-mm-high Teflon molds. Seventy microliters of
7.5% (w/v) PLA in methylene chloride (Sigma) was cast
into the molds. The solvent was evaporated under vac-
uum overnight and the salt porogen was removed by
soaking the mold in water for 48 h.
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Assembly of composites
The two phases of the scaffold were assembled before
cell seeding and implantation. A thin polyglycolic acid
(PGA) polymer film was placed between phases before
assembly to serve as a barrier to cell infiltration during
seeding and cell migration during growth (Fig. 1A).
Twenty microliters of a saturated 60° solution of PGA
(molecular weight not reported by the manufacturer, vis-
cosity in hexafluoroisopropanol reported as 1.71 dL/g;
Birmingham Polymers) in hexafluroisopropanol (Sigma)
was dropped onto a glass slide and the ceramic scaffold
was placed on top, thereby creating a film of PGA on
one face of the HA. This film was allowed to dry and
then peeled away from the cylinder circumference and
ceramic face, leaving only that film which covered the
opening of the pores (Fig. 1B). The two phases were then
assembled by spreading 10 L of 7.5% PLA in methyl-
ene chloride on the exposed ceramic face and pressing
the polymer sponge onto the ceramic base (Fig. 1C). Rods
that traversed the ceramic and polymer phases were used
to ensure a mechanically stable attachment between the
phases, as previously described31 (Fig. 1D). PLA in meth-
ylene chloride (25%, w/v) was extruded in a straight line
traversing both the ceramic and polymer phases. Com-
pleted scaffolds were allowed to dry overnight and ster-
ilized by soaking in 70% ethanol for 24 h.
Scaffold imaging
Final scaffolds were imaged by microcomputed to-
mography (CT) to visualize the internal structure, in-
cluding continuity of the interface between the PLA and
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FIG. 1. PLA was used to join the polymer and ceramic phases of the composite scaffold. One face of the ceramic was coated
with a thin film of PGA (A). The film was removed from the circumference and PLA was applied to the surface (B). The poly-
mer sponge was pressed onto the ceramic scaffold, allowing the solubilized PLA to serve as adhesive (C). PLA struts were ex-
truded on two opposite sides of the scaffold to further stabilize the composite (D).
HA phases. Scans were performed through air to enhance
contrast of the polymer phase on a model MS8-CMR-
100 scanner (EVS, London, ON, Canada) at 15-m-voxel
resolution and 80 kV. Noise was removed from the data
sets and three-dimensional renderings were made, using
custom routines written in IDL 5.5 (Research Systems,
Boulder, CO).
Cell culture
Articular cartilage was harvested from domestic pig
knee joints obtained from a local slaughterhouse. Carti-
lage was scraped from articulating surfaces with a scalpel
and diced into 1-mm3 cubes. Chondrocytes were isolated
with a 1.5-mg/mL solution of collagenase II (Sigma) 
in -minimum essential medium (-MEM) containing 
penicillin–streptomycin, kanamycin, and amphotericin B
(Fungizone; GIBCO, Frederick, MD). The tissue was di-
gested overnight at 37°C under agitation and the result-
ing cell suspension was filtered through a double nylon
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sieve (70-m pore size). The suspension was filtered and
centrifuged at 700  g for 10 min. The chondrocytes
were resuspended in culture medium (CM, -MEM with
10% FBS and 1% penicillin–streptomycin; GIBCO), and
plated in tissue culture flasks (BD Biosciences, Lexing-
ton, KY). After 24 h, adherent cells were used for cell
seeding.
Primary human gingival fibroblasts (HGFs) were pre-
pared from discarded tissue after oral surgery in compli-
ance with the University of Michigan Institutional Re-
view Board. Briefly, cells migrating from diced tissue
onto tissue culture polystyrene were isolated and ex-
panded in CM.33 Passage 4 fibroblasts were infected with
AdCMV-BMP-7, a recombinant adenovirus construct ex-
pressing the murine BMP-7 gene under the control of the
cytomegalovirus (CMV) promoter. The virus was created
by Cre–lox recombination as previously described.34 In-
fections were performed overnight with 1000 plaque-
forming units per cell. Such infected primary cells have
been shown to form bone in vivo.35–38
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FIG. 2. A three-dimensional reconstruction of CT data shows the polymer sponge phase (top), the HA phase (bottom, 300-
m pore design), and the polymeric struts that transverse both phases (arrow). A pie slice portion of the scaffold has been re-
moved from the image to reveal the pore architecture of the scaffold.
Cell seeding and scaffold implantation
A two-step process was used to seed cells into the poly-
mer and ceramic phases of the scaffold. Transduced
HGFs were suspended in bovine plasma-derived fibrino-
gen (50 mg/mL in -MEM; Sigma). Cells (106 in 20 L)
were pipetted into the ceramic phase of the composite
scaffold and the scaffold was immediately placed onto a
20-L drop of bovine plasma-derived thrombin (100
U/mL; Sigma). Fibrinogen gelation occurred quickly on
contact with the thrombin. To ensure complete gelation
throughout the scaffold volume, the scaffold was left
undisturbed in thrombin for 40 min. Chondrocytes were
suspended in CM and 106 cells in 20 L were pipetted
into the polymer sponge phase and allowed to adhere for
1 h in a 37°C incubator. The scaffolds were then imme-
diately implanted.
Twelve composite scaffolds were implanted subcuta-
neously into 5- to 8-week-old immunocompromised mice
(N:NIH-bg-nu-xid; Charles River, Wilmington, MA).
Animals were anesthesized with intramesenteric injec-
tions of ketamine–xylazine (50 and 5 g/g, respectively)
in saline. Dorsal subcutaneous pockets were created by
blunt dissection and four composite scaffolds were in-
serted into each mouse. Surgical sites were closed with
wound clips.
Evaluation of implants
Mice were killed after 4 weeks. The harvested implants
were fixed with Z-Fix (Anatech, Battle Creek, MI) and
stored in 70% ethanol for microcomputed tomography
(CT) analysis and paraffin processing. Specimens were
CT scanned in distilled water at 10-m-voxel resolu-
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tion. Three-dimensional isosurface renderings were made
with MicroView v 1.1.1 (GE Medical Systems, London,
ON, Canada) to visualize bone and ceramic.
Specimens were then demineralized with RDO (APEX
Engineering Products, Plainfield, IL).31 The demineral-
ization process also removed the HA phase of the scaf-
fold. The specimens were then embedded in paraffin, sec-
tioned at 7 m, and stained with either hematoxylin and
eosin (H&E) or with safranin O and fast green. The
safranin O stained glycosaminoglycans (GAGs) red and
the fast green stained collagenous tissues brown.
RESULTS
The final manufactured composite scaffolds matched
the image based design. The PLA polymer sponge con-
sisted of 50- to 100-m-wide interconnected pores as ev-
idenced by CT. A slight separation between the PLA
sponge and HA ceramic phases was visible in the CT
(Fig. 2). The PLA rods connecting the phases were in in-
timate contact with both the PLA and HA phases. The
integrity of the composite scaffold was sufficient to with-
stand surgical manipulation and subsequent implantation.
To determine the potential for the growth and differ-
entiation of bone and cartilage on the scaffolds, cells were
loaded into the biphasic scaffold and implanted. Four
weeks after implantation, the constructs were removed
and analyzed. The implants were encapsulated in soft
connective tissue and no necrotic tissue or inflammation
was observed in any of the animals. Demineralization of
the implants allowed paraffin sectioning of the scaffold
by removing the ceramic portion of the scaffold; in his-
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FIG. 3. Scaffolds were demineralized before sectioning, resulting in empty areas (marked with asterisks) that were previously
occupied by HA. Safranin O and fast green staining showed a large area of pink-stained cartilage (arrow) in the polymer sponge,
in contact with the green–brown-stained bone formed in the ceramic phase (A). Small pockets of cartilage were also observed
within the pores of the ceramic phase of the scaffold (C, arrow). Comparison with H&E sections showed that this tissue was ad-
jacent to areas of tissue that stained positive for eosin, but contained rounded chodrocyte-like cells (B, arrows). H & E staining
showed the formation of bone and marrow throughout the ceramic scaffold (D). All sections are from an HA scaffold with 300-
m pores.
tological sections, areas that were formerly occupied by
HA appear empty (white). Safranin O staining revealed
the presence of GAGs in the PLA sponge of the scaffold,
indicating chondrocyte synthesis of cartilage matrix (Fig.
3A). The centers of the sponge displayed low safranin O
staining whereas the outer regions and interface with the
HA ceramic displayed strong staining. Apical regions of
the polymer sponge consistently stained with safranin O.
Cartilage was found in intimate contact with the ceramic
and infiltrating the ceramic pores at the polymer–ceramic
interface. Small pockets of cartilage were also observed
deep within the pores of the ceramic phase (Fig. 3C).
Comparison of adjacent sections stained with hema-
toxylin and eosin suggests that some regions of cartilage
tissue within pores underwent mineralization as evi-
denced by the strong eosin stain and hypertrophic chon-
drocyte morphology (Fig. 3B). This mineralized cartilage
was also present at the interface between the polymer and
ceramic phases of the composite. These results were con-
firmed by the three-dimensional reconstructions of the
CT data. CT scans demonstrated mineralized tissue at
the interface between the polymer sponge and porous ce-
ramic, in intimate contact with the HA phase (Fig. 4).
Significant bone growth was observed in the pores of the
HA phase and on the HA outer surface, often filling the
pore openings with bone. In addition, smaller mineral-
ized regions were observed in the PLA phase near the
cylinder walls of the sponge.
Several other tissue types were found in the compos-
ite scaffolds. Blood vessels were observed in the ceramic
but not the polymer phases of the composite. Vessels
were oriented longitudinally along the length of ceramic
pores, within fibrous and bone tissue and traversed into
the central region of the ceramic phase (Fig. 5). Fibrous
tissue was observed within both the ceramic and poly-
meric phases of the tissue. Within the HA scaffold pores,
a variety of tissue types were observed, including bone,
fatty tissue, blood vessels, and marrow stroma (Fig. 3D).
DISCUSSION
The objective of this study was to utilize materials and
biological factors in an integrated approach to regener-
ate a multitissue interface. Our results demonstrate that
IBD and SFF-manufactured biphasic polymer–ceramic
scaffolds support the concurrent formation of bone and
cartilage in discrete phases of the assembled scaffold to
generate an integrated tissue-engineered osteochondral
construct. Concurrent tissue growth provided for the de-
velopment of a mineralized tissue interface between car-
tilage in the PLA sponge phase and bone in the HA ce-
ramic phase (Figs. 3 and 4). This interface tissue should
provide a transition in stiffness between the regenerated
cartilage and bone. However, some regions of the inter-
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face were devoid of this mineralized tissue and instead
displayed cartilage in intimate contact with the ceramic.
The SFF-designed channels within the ceramic phase
guided vascularization, a process that is critical to pro-
duce a biologically functional tissue. These scaffolds also
supported the growth of fat and stroma, demonstrating
their potential to fully mimic native skeletal tissue. Taken
together, SFF-manufactured biphasic scaffolds differen-
tially seeded with osteo- and chondroprogenitors can gen-
erate osteochondral tissue resembling native tissue, in-
cluding vascular subchondral bone and an interface tissue
between bone and articular cartilage that is similar to the
tidemark seen in articulating surfaces. The design and
composition of the scaffolds may be modified to satisfy
the mechanical requirements in a skeletal site.27
The combined use of gene therapy and SFF biphasic
scaffolds represents a new strategy for the repair of hu-
man osteochondral defects and for joint replacement. Be-
cause human defects will be comparatively large, seed-
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FIG. 4. Three-dimensional reconstructions of CT data of the
ceramic phase of the scaffolds demonstrated that bone was ex-
tensive and occluded the ceramic pores (diameter, 300 m).
Small amounts of mineralized tissue were also present in the
polymer phase of scaffold. The polymer sponge, while intact,
did not appear in the CT image, because of the scanning pro-
tocol used (A). A cross-sectional view of an HA phase (shown
in gray; pore diameter, 800 m) shows scattered bone (white)
growth within and around the scaffold (B).
ing of implants with cells may be necessary to provide a
cell pool for tissue regeneration. A similar lack of re-
generative cells may be problematic in human defects in
which disease or therapeutic irradiation have depleted
progenitor cell polulations.39–42 In this study, we have
demonstrated that implantation of our cell-containing
scaffolds led to growth of skeletal tissues in a nonortho-
topic (subcutaneous) site, in which a similar lack of pro-
genitor cells exists. Bone formation was induced by the
presence of nonosseous progenitor cells transduced with
a BMP-7 adenoviral construct. This gene therapy ap-
proach provides for bone formation from cell populations
that are easily harvested and expanded compared with os-
teoblasts or bone marrow stromal cells.37,38
The SFF biphasic scaffolds are advantageous for sev-
eral reasons. They can be designed to fit patient-specific
injuries and match articular surface geometry, using de-
fect imaging and IBD.30 The biphasic components can
be used to differentially regulate cell differentiation and
growth, promoting the regeneration of bone and vascu-
lature in the ceramic component while maintaining the
growth of cartilage in the polymeric component. Each
phase may be differentially seeded or loaded with growth
and gene therapy factors. In addition, biphasic SFF scaf-
folds may be designed to carry functional loads.43 The
IBD and SFF methods described here can be applied to
create larger scaffolds for human skeletal defects. Such
scaffolds will likely be exposed to larger mechanical
forces than those present in this model, particularly if
they are used in load-bearing orthotopic sites.
To create a strong mechanical interface between the
ceramic and polymer phases of a larger composite scaf-
fold, a number of polymeric struts, similar to the rods
created on the sides of the small implants used in this
study, may be required. We have previously demon-
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strated manufacture of such scaffolds with polymeric
struts.31 Although the effect of polymeric struts on bone
and cartilage regeneration is a current subject of study,
such struts are similar in size and composition to the PLA
pins and screws increasingly used in clinical practice for
cartilage and bone anchoring.44–46 IBD coupled with SFF
fabrication provides great flexibility in the design and
manufacture of scaffolds to meet a variety of often con-
flicting clinical requirements, such as minimizing the
number of struts while maintaining sufficient mechani-
cal properties.
Although the biphasic scaffolds were designed to con-
trol cell seeding, greater control over the spatial distribu-
tion of regenerate tissue is desired. The polymer phase dis-
played low safranin O staining in the sponge centers,
indicating the absence of cartilage. Chondrocyte infiltra-
tion into the polymer sponge may have been hindered by
the 50- to 100-m pore size. Larger pores with enhanced
interconnectivity are likely required to achieve uniform
seeding. In addition, small amounts of mineralized tissue
were observed in some constructs within the polymer
phase that may have been the result of transduced HGF
migration or diffusion of BMP-7. BMP-7 produced by the
fibroblast in the ceramic phase may also have initiated os-
teogenesis by the chondrocytes in the polymeric phase.
The mineralized tissue interface between bone and car-
tilage consisted of mineralized cartilage and was often
present at the junction of the polymer and ceramic phases
of the composite, as evidenced by the safranin O and
eosin stain and hypertrophic chondrocyte cell morphol-
ogy (Fig. 3). However, cartilage was also found in direct
apposition with the ceramic at the polymer–ceramic in-
terface. The PGA barrier over the ceramic pores may
have prevented osteoblasts from interacting with chon-
drocytes in these regions and from producing a bone–car-
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FIG. 5. H & E staining of blood vessels that grew in the HA phase of the scaffolds; arrows show a vessel within bone (per-
pendicular to pore cross-section) (A), and another growing through fibrous tissue along the length of the pore, demonstrating
that vessel growth was directed by the pore structure of the HA (B).
tilage interface. In addition, pockets of tissue within the
ceramic phase stained positive for glycosaminoglycans
(GAGs), indicating the presence of cartilage. These pock-
ets were often located next to mineralized cartilage (Fig.
3). The origin of this cartilage is unclear. It is possible
that the PGA barrier over the ceramic pores failed to pre-
vent some chondrocytes from infiltrating the ceramic
phase during seeding. However, it is also possible that
the BMP-7-transduced HGFs may have induced cartilage
formation. BMP-7 is known to induce bone formation via
endochondral ossification.47–50 Considering that virally
transduced HGFs secrete BMP-7 that may act on host
cells, it is also possible that the cartilage tissue is of host
origin. Host cells exposed to the BMP-7 may have un-
dergone delayed endochondral ossification relative to that
of the implanted HGFs and yielded a chimeric tissue.38
Modifications to the cell-seeding method may be used to
minimize the presence of undesired cell types in either
phase of the scaffold. In addition, lower numbers of trans-
duced cells may be used to decrease the local concen-
tration of BMP-7. Finally, advanced understanding of
how the scaffold internal architecture regulates interface
tissue formation may be used to enhance formation of a
uniform mineralized tissue interface between bone and
cartilage similar to the tide mark.
In conclusion, image-based design (IBD) and solid
free-form (SFF)-manufactured hydroxyapatite (HA)
and poly(L-lactide) PLA biphasic composite scaffolds,
coupled with differential cell seeding and gene therapy,
generated osteochondral tissue, including cartilage, vas-
cularized bone, and an organized bone–cartilage inter-
face. In an ectopic site, the tissue formation was not
highly uniform, but these results suggest that these
methods will be effective in regenerating osteochondral
tissue in situ. We hope to test the performance of a sim-
ilar construct in an orthotopic site and further investi-
gate mechanical performance, implant degradation, and
tissue formation. IBD and SFF fabrication can be used
to manufacture biphasic composites that are capable of
carrying functional loads on implantation, replicating
articular surface geometry, and promoting integration
with host tissues. The use of an integrated composite
manufactured via SFF fabrication coupled with the use
of osteo- and chondroprogenitor cells in situ is a promis-
ing strategy for the regeneration of functional articular
surfaces.
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